Last reviewed: June 7, 2026
Last updated: June 7, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
After weeks of gradual dose increases, your semaglutide therapy reaches a stable point where your body responds optimally—this is your maintenance dose. Most patients find their therapeutic window between 1.0 and 2.4 mg weekly, though individual needs vary significantly based on metabolic factors and GLP-1 receptor sensitivity.
What Is Semaglutide Maintenance Dose and Why It Matters
A maintenance dose represents the amount of semaglutide that delivers consistent appetite suppression and metabolic benefits without further escalation. Unlike the titration phase—where doses climb from 0.25 mg to find your therapeutic level—maintenance is your steady-state target where weight loss stabilizes and side effects typically diminish. This phase typically begins after 4 to 16 weeks of dose increases, depending on your individual tolerance and response.
Reaching maintenance means your GLP-1 receptors have adapted to the medication, your hunger signals are durably reset, and your body has found its new metabolic equilibrium. At this point, most people report that food cravings decrease significantly, portion control feels natural, and energy levels stabilize. The maintenance phase is where the real, sustainable work happens—it's not the beginning of your journey, but rather the foundation for long-term success.
How Your Body Determines the Right Maintenance Level
Your maintenance dose isn't arbitrary; it's determined by how your GLP-1 receptors respond to the medication and how your metabolism processes it. Factors like body weight, kidney function, liver health, and genetic variations in GLP-1 receptor sensitivity all influence where your sweet spot lands. Some patients feel their best at 0.5 mg weekly, while others require 2.0 mg or higher to achieve the same appetite-suppressing effect.
PlexusDx's Precision Peptide Genetic Test identifies key variants—including GLP1R rs6923761 and GIPR rs1800437—that predict how efficiently your body's peptide pathways respond to semaglutide. Patients with certain genetic profiles may reach effective maintenance at lower doses, while others benefit from higher therapeutic targets. This personalized insight removes guesswork and helps your provider establish your maintenance dose faster, with fewer unnecessary increases.
The Difference Between Titration and Maintenance Phases
During titration, you start low (typically 0.25 mg weekly) and increase gradually—usually every week or every four weeks—until you find your dose. This phase teaches your body to tolerate the medication while minimizing nausea and gastrointestinal side effects. Once you stop increasing and hold steady at one dose for several weeks with good tolerability and weight loss results, you've entered maintenance.
Maintenance isn't a plateau where nothing changes; it's a stabilized period where your medication dose remains constant while your habits and lifestyle continue evolving. Some patients stay on the same maintenance dose for months or years, while others may adjust slightly up or down based on life changes, activity level, or weight-loss goals. The key difference is intention: titration aims to find your dose, while maintenance aims to sustain your results.
Common Maintenance Dose Ranges and Expectations
Clinical trials and real-world data show that effective maintenance doses for semaglutide typically fall between 0.5 mg and 2.4 mg weekly. Many patients achieve significant weight loss at 1.0 mg weekly, the dose used in landmark GLP-1 obesity trials. Higher doses aren't always better—individual response matters far more than absolute dose amount, and going beyond your therapeutic window often increases side effects without additional benefit.
At maintenance, patients usually notice steady weight loss of 1 to 2 pounds per week, decreased appetite intensity, improved blood sugar control, and reduced cravings for high-calorie foods. Side effects often become milder or resolve entirely as your body adapts. If you're experiencing unmanageable nausea or other adverse effects after several weeks on your maintenance dose, this signals a need to adjust—either downward for tolerability or with dietary and hydration modifications to support your current level.
How PlexusDx Supports Your Maintenance Phase
PlexusDx Compounded Semaglutide Injection starts at $149 per month across all three commitment tiers, with pricing that never increases based on your dose—your dose may need to go up, but your price won't. This flat-rate model removes barriers to finding your true maintenance dose without fear of escalating costs. All medications come from licensed 503A compounding pharmacies, are available in all 50 states without insurance requirements, and are HSA and FSA eligible.
Once you've established your maintenance dose and begun seeing results, PlexusDx's Precision Peptide Genetic Test ($99 add-on after your first month) reveals how your 14 peptide pathways and 49 individual peptides interact with your therapy. This insight helps your care team understand whether your current maintenance level aligns with your genetic predispositions—and whether adjustments or alternative compounds like tirzepatide might offer even better long-term outcomes. PlexusDx maps over 150 genetic insights to keep your maintenance strategy personalized.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
How long does it take to reach my semaglutide maintenance dose?
Most patients reach maintenance within 4 to 16 weeks of starting semaglutide, depending on how quickly your provider escalates doses and how your body tolerates each step. Once you've held the same dose for 3 to 4 weeks with good tolerability and consistent weight loss, you're likely at maintenance. Some people reach it faster; others benefit from a longer, slower titration to minimize nausea.
Will my maintenance dose change over time?
Your maintenance dose may shift slightly over months or years based on changes in weight, activity, metabolism, or life circumstances—but stable maintenance often persists for extended periods without adjustment. If weight loss plateaus significantly or side effects emerge, your provider may recommend a small increase, decrease, or switch to a complementary compound. The goal of maintenance is consistency, not constant change.
Can genetic testing help me find my maintenance dose faster?
Yes. PlexusDx's Precision Peptide Genetic Test identifies variants in GLP1R and GIPR that influence how your body responds to semaglutide, helping your provider predict your likely therapeutic range before extensive trial and error. Patients with insights into their peptide pathways often reach their true maintenance dose with fewer unnecessary increases and better-informed dosing decisions.
What happens if my current dose isn't working at maintenance?
If you've been stable on a dose for 8+ weeks but weight loss has stalled or appetite hasn't adequately decreased, a modest increase may be warranted—or a switch to a dual-compound therapy like GLP-Squared (semaglutide plus tirzepatide). PlexusDx pricing never increases with dose escalation, so adjusting your maintenance is financially risk-free.
Is maintenance dose the same for everyone on semaglutide?
No. Maintenance doses vary widely due to differences in body composition, GLP-1 receptor genetics, kidney and liver function, and individual metabolic rate. Some people achieve excellent results at 0.5 mg weekly, while others need 2.0 mg or higher. Your maintenance dose is unique to you, and genetic insights from PlexusDx testing can explain why your needs differ from others.
Will I need to stay on my maintenance dose forever?
Maintenance duration is individual; many people continue for months or years, while others eventually transition off with lifestyle changes intact. Your healthcare provider will help determine when and whether dose adjustments make sense based on your long-term goals. Stopping semaglutide is a decision to discuss with your provider, as appetite and eating patterns may shift.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Where is GLP-1 Secreted? Understanding Its Role in Metabolism and Health
How Often Can You Take Ozempic for Weight Loss?